cremophor el has been researched along with Cystadenocarcinoma, Serous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonfrer, JM; Hageman, PC; Hilkens, JG; Korse, CM; Linders, TC; Molthoff, CF | 1 |
1 other study(ies) available for cremophor el and Cystadenocarcinoma, Serous
Article | Year |
---|---|
Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cell Count; Cystadenocarcinoma, Serous; Female; Glycerol; Humans; Immunohistochemistry; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Tumor Cells, Cultured | 1997 |